News & Updates

Show Multimedia Only
Hypertension in pregnancy: Labetalol extends benefits for pregnancy outcomes Hypertension in pregnancy: Labetalol extends benefits for pregnancy outcomes

Hypertension in pregnancy: Labetalol extends benefits for pregnancy outcomes

22 Feb 2022 byJairia Dela Cruz

Common blood pressure (BP)-lowering medications in pregnancy cut the risk of severe hypertension, but labetalol has the added advantage of reducing the risks of proteinuria or pre-eclampsia and perinatal death, according to the results of a network meta-analysis.

22 Feb 2022
NOACs preferable over warfarin in AF patients with bioprosthetic valves

NOACs preferable over warfarin in AF patients with bioprosthetic valves

22 Feb 2022 byStephen Padilla

Use of nonvitamin K oral anticoagulants (NOACs) results in a reduced incidence of thromboembolic events and major bleeding relative to warfarin in patients with atrial fibrillation (AF) and bioprosthetic valves or valve repair, suggests a study.

22 Feb 2022
Lipoprotein(a) molar concentrations help inform cardiovascular risk

Lipoprotein(a) molar concentrations help inform cardiovascular risk

19 Feb 2022

The risk of coronary artery disease (CAD) can be predicted by a single accurate measurement of lipoprotein(a) molar concentration if therapies substantially altering lipoprotein(a) are not present, suggests a recent study.

19 Feb 2022